T1	Participants 462 565	ages of 18 and 50 years who were addicted to opioids (e.g., heroin) and not currently in drug treatment
T2	Participants 1157 1169	125 patients
T3	Participants 1197 1255	57 selected clonidine and 68 selected clonidine/naltrexone
